Nanome Webinar Series
Upcoming Webinars
Virtual Reality to Aid Antidote Design:
Structure-based design to treat organophosphate poisoning
June 22nd, 2022
Live Webinar at 10am PST | 1pm EST | 7pm CET
Meet the speaker in VR at 11:00-11:30 am PST | 2:00-2:30pm EST | 8:00-8:30pm CET

Zoran Radic, PhD
Past Webinars

Brian Atwood, PhD

Rohit Arora, PhD
AI for the Science Metaverse:
how to accelerate drug discovery by using AI in VR
Recorded May, 26th, 2022
Iktos AI-technologies for generative chemistry and retrosynthesis planning
Makya web application: AI for de novo drug design
Spaya web application: AI for discovering and prioritizing synthetic routes
Using Iktos tools in Nanome: a perfect place to collaborate

Andrey Kovalevsky, PhD
Designing from "inside" the COVID-19 viral protein:
A novel chemical structure designed in VR
Recorded January, 26th, 2022
Novel chemical structures for inhibiting SARS-CoV-2 replication
VR-assisted structure-activity relationships
Why Oak Ridge National Laboratory combines neutrons and VR for structure-based drug design
How VR aids collaboration between structural biologists, medicinal chemists, and molecular modelers

Jackie von Salm, PhD
Psychedelics & Virtual Reality: How VR aids GPCR drug discovery for a psychedelic biotech startup
Recorded Wednesday, November 17th, 2021
Why psychedelic research is so promising & what's on the horizon
Overcoming the challenges of communicating scientific research to investors
Easy ways to improve spatial awareness of chemists and the impact that brings to the lab
How Psilera is using Nanome to filter compounds
View on Demand

Wilian Cortopassi
The "Virtual" Reality of Drug Discovery at Novartis
Recorded Thursday, October 21st, 2021
How Novartis is using Virtual Reality across different research sites globally (US and Switzerland)
A case study of the main protease (Mpro) of SARS-CoV-2
Future outlook of VR at Novartis
A recording of this webinar is not available. Click below to download our case study with Novartis instead.

Woody Sherman
The Roivant Discovery vision for physics-driven drug design and the role of virtual reality to maximize insights.
Recorded Tuesday, August 24th, 2021
What Roivant Discovery is doing with physics-driven drug design.
The importance of structure-based drug discovery.
Why VR is the next step to fully realize the benefit of structure-based drug discovery for visualization, collaboration, and design.